NO975832D0 - Fremgangsmåter for forhindring eller behandling av allergier - Google Patents

Fremgangsmåter for forhindring eller behandling av allergier

Info

Publication number
NO975832D0
NO975832D0 NO975832A NO975832A NO975832D0 NO 975832 D0 NO975832 D0 NO 975832D0 NO 975832 A NO975832 A NO 975832A NO 975832 A NO975832 A NO 975832A NO 975832 D0 NO975832 D0 NO 975832D0
Authority
NO
Norway
Prior art keywords
procedures
preventing
treating allergies
allergies
treating
Prior art date
Application number
NO975832A
Other languages
English (en)
Other versions
NO321504B1 (no
NO975832L (no
Inventor
Erika Isolauri
Leena Metsaeniitty
Hannu Korhonen
Seppo Salminen
Eeva-Liisa Syvaeoja
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8543602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO975832(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Valio Oy filed Critical Valio Oy
Publication of NO975832D0 publication Critical patent/NO975832D0/no
Publication of NO975832L publication Critical patent/NO975832L/no
Publication of NO321504B1 publication Critical patent/NO321504B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19975832A 1995-06-14 1997-12-11 Fremgangsmater for in vitro fremstilling av proteinhydrolysatsammensetning, oral proteinhydrolysatsammensetning og anvendelser derav. NO321504B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (fi) 1995-06-14 1995-06-14 Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
PCT/FI1996/000350 WO1997000078A1 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies

Publications (3)

Publication Number Publication Date
NO975832D0 true NO975832D0 (no) 1997-12-11
NO975832L NO975832L (no) 1997-12-11
NO321504B1 NO321504B1 (no) 2006-05-15

Family

ID=8543602

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975832A NO321504B1 (no) 1995-06-14 1997-12-11 Fremgangsmater for in vitro fremstilling av proteinhydrolysatsammensetning, oral proteinhydrolysatsammensetning og anvendelser derav.

Country Status (27)

Country Link
US (2) US6506380B1 (no)
EP (1) EP0833649B2 (no)
JP (1) JP3983804B2 (no)
KR (1) KR100494741B1 (no)
CN (1) CN1154506C (no)
AR (1) AR003960A1 (no)
AT (1) ATE230606T1 (no)
BG (1) BG63153B1 (no)
BR (1) BR9607827A (no)
CA (1) CA2224320C (no)
CZ (1) CZ291904B6 (no)
DE (1) DE69625690T3 (no)
DK (1) DK0833649T4 (no)
EE (1) EE03424B1 (no)
ES (1) ES2191103T5 (no)
FI (1) FI104465B (no)
HK (1) HK1010081A1 (no)
IL (1) IL122577A0 (no)
MX (1) MX9710109A (no)
MY (1) MY113912A (no)
NO (1) NO321504B1 (no)
NZ (1) NZ310478A (no)
PL (1) PL185123B1 (no)
RO (1) RO120243B1 (no)
SK (1) SK284245B6 (no)
WO (1) WO1997000078A1 (no)
ZA (1) ZA965088B (no)

Families Citing this family (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
WO1998054982A1 (en) * 1997-06-03 1998-12-10 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with sids
AU3210100A (en) 1999-01-19 2000-08-01 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
CN1186440C (zh) 1999-08-05 2005-01-26 雀巢制品公司 预防病原性细菌引起的腹泻的新双歧杆菌
AU6698000A (en) 1999-08-05 2001-03-05 Societe Des Produits Nestle S.A. Bifidobacteria capable of preventing diarrhea
WO2001057534A2 (en) * 2000-02-04 2001-08-09 Bioseek Compositions and methods for reducing autoimmunity
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
AU2056102A (en) * 2000-09-25 2002-04-02 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
EP1593382A1 (en) * 2000-10-06 2005-11-09 Société des Produits Nestlé S.A. Use of probiotic lactic bacteria for balancing the skin's immune system
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1228707A1 (en) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
KR20030088453A (ko) * 2001-03-09 2003-11-19 소시에떼 데 프로듀이 네슬레 소시에떼아노님 연령 관련 생리학적 부전 개선 및 수명 연장을 위한 조성물
JP2003137804A (ja) * 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−18誘導剤
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
US20050256057A1 (en) 2002-06-04 2005-11-17 Luppo Edens Protein hydrolysate rich in tripeptides
WO2004003235A2 (en) 2002-06-28 2004-01-08 Puleva Biotech, S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
CN101671680B (zh) 2004-02-25 2012-11-28 先锋高级育种国际公司 新的苏云金芽孢杆菌晶体多肽、多核苷酸及其组合物
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
CA2604338A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
AU2006313660B2 (en) * 2005-11-14 2012-07-19 Nestec S.A. Oral tolerance promotion with glycated proteins
MY148872A (en) 2006-02-15 2013-06-14 Nestec Sa Use of bifidobacterium longum for the prevention and treatment of inflammation
RU2448720C2 (ru) 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
MX2008015690A (es) * 2006-06-15 2008-12-19 Nestec Sa Induccion de tolerancia a proteinas de huevo.
MX2009008875A (es) * 2007-02-28 2009-08-28 Mead Johnson Nutrition Co Producto que contiene probiotico inactivado para niños o infantes.
CN101273737B (zh) 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974734A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
CN101784669B (zh) 2007-08-24 2015-02-18 科德克希思公司 用于(r)-3-羟基四氢噻吩的立体选择性制备的改善的酮还原酶多肽
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
KR20100120169A (ko) 2008-01-24 2010-11-12 네스텍 소시에테아노님 영양 성분을 담고 있는 캡슐 및 이 캡슐로부터 영양액을 전달하는 방법
ES2585407T3 (es) 2008-02-01 2016-10-05 Murdoch Childrens Research Institute Un método para inducir tolerancia a un alérgeno
AU2009224814B2 (en) 2008-03-14 2015-02-05 Société des Produits Nestlé S.A. Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
WO2009152336A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
CN102131813B (zh) 2008-06-24 2014-07-30 科德克希思公司 用于制备基本上立体异构纯的稠合二环脯氨酸化合物的生物催化方法
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP2329013B1 (en) 2008-08-27 2015-10-28 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
DK3354727T3 (da) 2009-01-08 2020-11-16 Codexis Inc Transaminasepolypeptider
EP2408908B1 (en) 2009-03-17 2015-05-27 Codexis, Inc. Variant endoglucanases and related polynucleotides
EP2414506B1 (en) 2009-03-31 2017-05-03 Codexis, Inc. Improved endoglucanases
EP2443139B1 (en) 2009-06-16 2016-08-10 Codexis, Inc. Beta-glucosidase variant enzymes and related polynucleotides
EP3409765B1 (en) 2009-06-22 2021-08-04 Codexis, Inc. Ketoreductase-mediated stereoselective route to alpha chloroalcohols
WO2011011630A2 (en) 2009-07-23 2011-01-27 Codexis, Inc. Nitrilase biocatalysts
IN2012DN00878A (no) * 2009-08-18 2015-05-22 Nestec Sa
CA2770062A1 (en) * 2009-08-18 2011-02-24 Nestec S.A. A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
ES2575560T3 (es) 2009-08-19 2016-06-29 Codexis, Inc. Polipéptidos cetorreductasa para preparar fenilefrina
EP2473604B1 (en) 2009-09-04 2017-01-11 Codexis, Inc. Variant cbh2 cellulases and related polynucleotides
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
HUE037123T2 (hu) 2009-09-18 2018-08-28 Codexis Inc Csökkentett kodon mutagenezis
DK2504017T3 (en) 2009-11-25 2014-03-03 Codexis Inc RECOMBINANT BETA-glucosidase OPTIONS FOR PRODUCTION OF soluble sugars FROM cellulosic biomass
EP2504431A4 (en) 2009-11-25 2013-10-16 Codexis Inc RECOMBINANT BETA-GLUCOSIDASE VARIANTS OF THERMOASCUS AURIENTIACUS FOR THE PRODUCTION OF FERMENTABLE SUGARS FROM CELLULOSIC BIOMASS
SI2510089T1 (sl) 2009-12-08 2015-12-31 Codexis, Inc. Sinteza prazolnih spojin
RU2563355C2 (ru) 2009-12-08 2015-09-20 Нестек С.А. Смесь для грудных детей с пробиотиками и компонентами оболочек жировых шариков молока
BR112012016290A2 (pt) 2009-12-31 2015-09-01 Pioneer Hi Bred Int Ácido nucléico isolado ou recombinante, cassete de expressão, célula hospedeira não humana, planta e semente transgênica, variante de polipeptídeo oxox isolado ou recombinante, método de modulação do nível de proteina oxalato oxidase (oxox) em uma planta ou célula vegetal, método para aumentar a resistência de uma planta a um patógeno, planta resistente a patógeno, método para identificar variantes oxox com atividade de oxox mantida ou aumentada, método para gerar uma planta que tem resistência aumentada a uma patógeno
EP2566497B1 (en) 2010-05-04 2015-07-29 Codexis, Inc. Biocatalysts for ezetimibe synthesis
EP2569331A1 (en) 2010-05-10 2013-03-20 Perseid Therapeutics LLC Polypeptide inhibitors of vla4
WO2011150313A1 (en) 2010-05-28 2011-12-01 Codexis, Inc. Pentose fermentation by a recombinant microorganism
US8852900B2 (en) 2010-06-17 2014-10-07 Codexis, Inc. Biocatalysts and methods for the synthesis of (S)-3-(1-aminoethyl)-phenol
WO2012006114A2 (en) 2010-06-28 2012-01-12 Codexis, Inc. Fatty alcohol forming acyl reductases (fars) and methods of use thereof
WO2012003299A2 (en) 2010-06-30 2012-01-05 Codexis, Inc. Highly stable beta-class carbonic anhydrases useful in carbon capture systems
WO2012024100A2 (en) 2010-08-16 2012-02-23 Merck Sharp & Dohme Corp. Process for preparing aminocyclohexyl ether compounds
DK2606131T3 (en) 2010-08-20 2017-06-19 Codexis Inc Use of proteins from glycoside hydrolase 61 family for cellulose processing
HUE037616T2 (hu) 2010-12-08 2018-09-28 Codexis Inc Biokatalizátorok és eljárások armodafinil szintéziséhez
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
WO2012135110A1 (en) 2011-03-30 2012-10-04 Codexis, Inc. Pentose fermentation by a recombinant microorganism
EP2697662B1 (en) 2011-04-13 2018-06-06 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
UA111078C2 (uk) * 2011-05-03 2016-03-25 Нестек С.А. Гідролізат білкового субстрату і спосіб його виготовлення
WO2013003219A1 (en) 2011-06-30 2013-01-03 Codexis, Inc. Pentose fermentation by a recombinant microorganism
BR112014004171A2 (pt) 2011-08-22 2018-11-06 Codexis Inc variantes da proteína glicósideo hidrolase gh61 e cofatores que aumentam a atividade de gh61
EP2753640B1 (en) 2011-09-08 2016-03-09 Codexis, Inc. Biocatalysts and methods for the synthesis of substituted lactams
EP2760997A4 (en) 2011-09-30 2015-02-11 Codexis Inc MUSHROOM PROTEASE
US20130084271A1 (en) * 2011-10-03 2013-04-04 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
US9139819B2 (en) 2011-11-18 2015-09-22 Codexis, Inc. Biocatalysts for the preparation of hydroxy substituted carbamates
BR112014015030A2 (pt) 2011-12-20 2017-06-13 Codexis Inc variantes da endoflucanase 1b (eg1b)
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
CN104508126B (zh) 2012-03-23 2017-06-30 科德克希思公司 用于合成色胺和色胺类似物的衍生物的生物催化剂和方法
WO2013169725A2 (en) 2012-05-08 2013-11-14 Codexis, Inc. Biocatalysts and methods for hydroxylation of chemical compounds
DK2847214T3 (en) 2012-05-11 2018-03-12 Codexis Inc CONSTRUCTED IMINE REDUCTIONS AND PROCEDURES FOR THE REDUCED AMINING OF KETON AND AMINE COMPOUNDS
EP2859096A4 (en) 2012-06-11 2016-05-11 Codexis Inc XYLANASES AND FUNGIC XYLOSIDASES
AU2013348272A1 (en) 2012-11-20 2015-05-14 Shell Internationale Research Maatschappij B.V. Pentose fermentation by a recombinant microorganism
DK2928865T3 (en) 2012-12-07 2018-06-18 Merck Sharp & Dohme BIOCATALYTIC TRANSAMINATION PROCEDURE
SG11201504752YA (en) 2012-12-21 2015-07-30 Codexis Inc Engineered biocatalysts and methods for synthesizing chiral amines
WO2014113521A1 (en) 2013-01-18 2014-07-24 Codexis, Inc. Engineered biocatalysts useful for carbapenem synthesis
WO2014133960A1 (en) 2013-02-28 2014-09-04 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
CN103355405A (zh) * 2013-04-07 2013-10-23 苏州旭优食品科技有限公司 一种低过敏性含乳制品的加工工艺
SI2986722T1 (sl) 2013-04-18 2019-07-31 Codexis, Inc. Umetni polipeptidi fenilalanin amonija liaze
EP3068793B1 (en) 2013-11-13 2021-02-17 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
US9605252B2 (en) 2014-04-16 2017-03-28 Codexis, Inc. Engineered tyrosine ammonia lyase
US9708587B2 (en) 2014-07-09 2017-07-18 Codexis, Inc. P450-BM3 variants with improved activity
CA2968275C (en) 2014-11-25 2023-09-12 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
PL3237621T3 (pl) 2014-12-22 2023-10-30 Codexis, Inc. Warianty ludzkiej alfa-galaktozydazy
US10696953B2 (en) 2015-02-10 2020-06-30 Codexis, Inc. Ketoreductase polypeptides for the synthesis of chiral compounds
JP6755886B2 (ja) 2015-05-07 2020-09-16 コデクシス, インコーポレイテッド ペニシリンgアシラーゼ
CN108271374B (zh) 2015-07-07 2021-09-21 科德克希思公司 具有改进的活性的新颖p450-bm3变体
US10724025B2 (en) 2016-05-05 2020-07-28 Codexis, Inc. Penicillin-G acylases
IL263448B2 (en) 2016-06-09 2023-10-01 Codexis Inc Biological catalysts and methods for hydroxylation of chemical compounds
US11299723B2 (en) 2016-06-15 2022-04-12 Codexis, Inc. Engineered beta-glucosidases and glucosylation methods
CA3032519A1 (en) 2016-08-26 2018-03-01 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
KR102696584B1 (ko) 2017-01-05 2024-08-19 코덱시스, 인코포레이티드 페니실린 g 아실라아제
CN110914445B (zh) 2017-02-03 2024-08-27 泰莱解决方案美国有限责任公司 工程化糖基转移酶和甜菊醇糖苷葡糖基化方法
SG11201906880VA (en) 2017-02-13 2019-08-27 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
EP3615513B1 (en) 2017-04-24 2022-07-20 Tesaro, Inc. Methods of manufacturing of niraparib
US11021729B2 (en) 2017-04-27 2021-06-01 Codexis, Inc. Ketoreductase polypeptides and polynucleotides
CA3062550A1 (en) 2017-05-08 2018-11-15 Codexis, Inc. Engineered ligase variants
EP3638688A4 (en) 2017-06-14 2021-07-07 Codexis, Inc. MODIFIED TRANSAMINASE POLYPEPTIDES INTENDED FOR INDUSTRIAL BIOCATALYSIS
CA3064577A1 (en) 2017-06-27 2019-01-03 Codexis, Inc. Penicillin-g acylases
RU2020103727A (ru) 2017-06-30 2021-07-30 Кодексис, Инк. Варианты рнк-полимеразы т7
EP3645711A4 (en) 2017-06-30 2021-04-21 Codexis, Inc. T7 RNA POLYMERASE VARIANTS
US11319531B2 (en) 2017-11-07 2022-05-03 Codexis, Inc. Transglutaminase variants
JP7401435B2 (ja) 2017-12-13 2023-12-19 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド カルボキシエステラーゼ生体触媒
CN111699250B (zh) 2017-12-13 2024-01-09 科德克希思公司 用于酰胺偶联的羧酸酯酶多肽
EP3807409A4 (en) 2018-06-12 2022-08-03 Codexis, Inc. MODIFIED TYROSINE AMMONIA-LYASE
CA3103819A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered pantothenate kinase variant enzymes
AU2019300837A1 (en) 2018-07-09 2021-01-07 Codexis, Inc. Engineered galactose oxidase variant enzymes
KR20210031926A (ko) 2018-07-09 2021-03-23 코덱시스, 인코포레이티드 조작된 퓨린 뉴클레오사이드 포스포릴라제 변이체 효소
KR20210031933A (ko) 2018-07-09 2021-03-23 코덱시스, 인코포레이티드 조작된 포스포펜토뮤타제 변이체 효소
CA3103721A1 (en) 2018-07-09 2020-01-16 Codexis, Inc. Engineered deoxyribose-phosphate aldolases
CN112672989A (zh) 2018-07-12 2021-04-16 科德克希思公司 工程化苯丙氨酸氨裂合酶多肽
CN112805295A (zh) 2018-07-30 2021-05-14 科德克希思公司 工程化糖基转移酶和甜菊醇糖苷葡糖基化方法
MX2021004925A (es) 2018-10-29 2021-06-15 Codexis Inc Variantes de adn-polimerasa modificadas.
SG11202105668PA (en) 2018-12-14 2021-06-29 Codexis Inc Engineered tyrosine ammonia lyase
JP2022515742A (ja) 2018-12-20 2022-02-22 コデクシス, インコーポレイテッド α-ガラクトシダーゼバリアント
WO2021013862A1 (en) 2019-07-23 2021-01-28 Frieslandcampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
EP4022049A4 (en) 2019-08-30 2023-11-01 Codexis, Inc. MODIFIED LIPASE VARIANTS
JP2022547523A (ja) 2019-09-12 2022-11-14 コデクシス, インコーポレイテッド 10-アセチル-3,7-ジヒドロキシフェノキサジンに対するペルオキシダーゼ活性
MX2022004017A (es) 2019-10-02 2022-05-02 Abbott Diabetes Care Inc Deteccion de analitos por medio de interruptores de proteinas.
JP2023507575A (ja) 2019-12-20 2023-02-24 コデクシス, インコーポレイテッド 操作された酸性アルファ-グルコシダーゼバリアント
EP4133064A4 (en) 2020-04-10 2024-07-24 Codexis Inc GENETICALLY ENGINEERED TRANSAMINASE POLYPEPTIDES
US11959108B2 (en) 2020-08-28 2024-04-16 Codexis, Inc. Engineered protease variants
CA3191900A1 (en) 2020-08-28 2022-03-03 Codexis, Inc. Engineered amylase variants
CA3201757A1 (en) 2020-12-11 2022-06-16 Mathias Schuetz Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors
CA3204825A1 (en) 2020-12-18 2022-06-23 Codexis, Inc. Engineered uridine phosphorylase variant enzymes
CA3214972A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered adenylate kinase variant enzymes
IL305928A (en) 2021-04-02 2023-11-01 Codexis Inc Transgenic enzymes of acetate kinase variant
US20220325285A1 (en) 2021-04-02 2022-10-13 Codexis, Inc. ENGINEERED CYCLIC GMP-AMP SYNTHASE (cGAS) VARIANT ENZYMES
CN117120599A (zh) 2021-04-02 2023-11-24 科德克希思公司 工程化鸟苷酸激酶变体酶
CA3220735A1 (en) 2021-05-21 2022-11-24 Codexis, Inc. Engineered methionine gamma lyase variants
CA3227215A1 (en) 2021-07-30 2023-02-02 Trish Choudhary Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids
CA3227236A1 (en) 2021-08-19 2023-02-23 Trish Choudhary Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023069921A1 (en) 2021-10-19 2023-04-27 Epimeron Usa, Inc. Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
WO2024150146A1 (en) 2023-01-12 2024-07-18 Novartis Ag Engineered ketoreductase polypeptides

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886288A (en) * 1970-06-15 1975-05-27 Swift & Co Cheese manufacture using highly active proteolytic enzymes
JPS5279086A (en) 1975-12-25 1977-07-02 Nippon Soda Co Ltd Preparation of antibiotic tunicamycin
JPS5279083A (en) * 1975-12-26 1977-07-02 Morinaga Milk Industry Co Ltd Production of protein decomposed substance not having bitterness and antigen property
JPS6041751B2 (ja) 1976-06-22 1985-09-18 ジエコ−株式会社 デジタル電子時計
JPS548785A (en) 1977-06-21 1979-01-23 Kikkoman Corp Preparation of protein hydrolyzate
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK589785A (da) * 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
DD281540A5 (de) * 1988-08-08 1990-08-15 Berlin Chemie Veb Verfahren zur herstellung von nutritiva
ATE113441T1 (de) 1989-10-02 1994-11-15 Sandoz Nutrition Ltd Proteinhydrolysaten.
JP3071877B2 (ja) 1991-06-27 2000-07-31 財団法人糧食研究会 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
ES2111625T3 (es) * 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
FI94089C (fi) 1992-12-10 1995-07-25 Valio Oy Menetelmä allergiaa aiheuttavien yhdisteiden poistamiseksi proteiinipitoisista koostumuksista
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
GB9312369D0 (en) * 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
AU1076595A (en) 1993-11-23 1995-06-13 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö

Also Published As

Publication number Publication date
IL122577A0 (en) 1998-06-15
CA2224320A1 (en) 1997-01-03
CZ399797A3 (cs) 1998-06-17
PL185123B1 (pl) 2003-02-28
US20030113340A1 (en) 2003-06-19
MY113912A (en) 2002-06-29
ES2191103T5 (es) 2009-11-03
JPH11510791A (ja) 1999-09-21
EP0833649B1 (en) 2003-01-08
MX9710109A (es) 1998-10-31
DE69625690D1 (de) 2003-02-13
JP3983804B2 (ja) 2007-09-26
EP0833649A1 (en) 1998-04-08
KR100494741B1 (ko) 2005-09-30
ZA965088B (en) 1997-01-22
CZ291904B6 (cs) 2003-06-18
CA2224320C (en) 2012-03-20
BG63153B1 (bg) 2001-05-31
WO1997000078A1 (en) 1997-01-03
EP0833649B2 (en) 2009-06-03
ATE230606T1 (de) 2003-01-15
DK0833649T3 (da) 2003-04-07
EE9700339A (et) 1998-06-15
BR9607827A (pt) 1999-11-30
ES2191103T3 (es) 2003-09-01
DE69625690T2 (de) 2003-11-06
US7172756B2 (en) 2007-02-06
RO120243B1 (ro) 2005-11-30
PL324010A1 (en) 1998-04-27
NO321504B1 (no) 2006-05-15
HK1010081A1 (en) 1999-06-11
NO975832L (no) 1997-12-11
SK284245B6 (sk) 2004-12-01
CN1154506C (zh) 2004-06-23
EE03424B1 (et) 2001-06-15
FI104465B (fi) 2000-02-15
DK0833649T4 (da) 2009-07-20
CN1187772A (zh) 1998-07-15
DE69625690T3 (de) 2009-12-24
AU710126B2 (en) 1999-09-16
FI952926A0 (fi) 1995-06-14
AU6127896A (en) 1997-01-15
AR003960A1 (es) 1998-09-30
US6506380B1 (en) 2003-01-14
SK171597A3 (en) 1998-11-04
KR19990022914A (ko) 1999-03-25
FI952926A (fi) 1996-12-15
NZ310478A (en) 2000-01-28
BG102144A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
NO975832D0 (no) Fremgangsmåter for forhindring eller behandling av allergier
NO973216D0 (no) Substituerte oksazolidin-calpain- og/eller cathepsin B-inhibitorer
DE69627026D1 (de) Osteosynthesevorrichtung
DE59608254D1 (de) Osteosynthesevorrichtung
DE19681419T1 (de) Behandlungssystem
NO982911D0 (no) FremgangsmÕte for behandling av depresjon
DE69621681D1 (de) Sicherheitssystem und Verfahren dafür
NO970786D0 (no) Fremgangsmåte for hemming av benprotesedegradering
DE69511299D1 (de) Sicherheitssystem
FI955333A0 (fi) Anordning foer rening av vatten
FI972182A (fi) Pienemmissä kirurgisissa leikkauksissa käytettävä suojaus
DE69621586D1 (de) Osteosynthesehilfsmittel
BR9505290A (pt) Protect
FI973780A0 (fi) Arrangemang foer bestaemning av laekemedelsdosering
FI954148A0 (fi) Foerfarande foer rening av roekgaser med hjaelp av elektroner
KR960010348U (ko) 노우즈 다운 방지 시스팀
FI2070U1 (fi) Anordning foer behandling av bikupor eller liknande
FI1942U1 (fi) Flaens foer faestande av foerdonssaete eller motsvarande skenanordning
FI951062A0 (fi) Foerfarande foer framstaellning av faergade betongstrukturer eller betongproduker
UA25833C2 (uk) Засіб для лікуваhhя мелаhомобластом
FI1455U1 (fi) Anordning foer invaendig rening av bruksvattenroernaet
FI941524A0 (fi) Foerfarande foer rening av vatten
FI941631A0 (fi) Foerfarande foer automatisering av en bionedbrytningstest (Sturm-test)
KR960002806U (ko) 보안시스템
FI1810U1 (fi) Anordning foer maetande av hoejd av vattnets yta

Legal Events

Date Code Title Description
MK1K Patent expired